FDA Approves MEROPENEM — Sandoz Inc

# FDA Approves Sandoz's Generic Meropenem for Intravenous Use Sandoz Inc. has received FDA approval for its generic meropenem injection, expanding the competitive landscape in the broad-spectrum carbapenem antibiotic market and potentially reducing treatment costs for healthcare systems. The approval of the intravenous formulation is expected to increase price competition and improve patient access to this critical infection treatment option.